首页> 外文期刊>Psychiatric genetics >Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease.
【24h】

Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease.

机译:载脂蛋白基因E4等位基因启动子多态性是阿尔茨海默氏病的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease is a complex neurodegenerative disorder, characterized by progressive cognitive decline and distinct neuropathology. The apolipoprotein gene E4 allele (APOE 4) is a major risk factor for the disease. Promoter polymorphisms at -491 and -427 may also contribute to the risk. We examined the two polymorphisms in 178 Alzheimer's patients and 141 controls. The -491AA genotype was overrepresented among the patients (68 versus 54%, P=0.01). However, in patients who were APOE4 carriers, the -491AA genotype more than doubled the risk [odds ratio (OR)=2.5; 95% confidence interval (CI)=1.2-5.4], especially in combination with -427TT [odds ratio (OR)=3.3; 95% confidence interval (CI)=1.5-7.7]. Moreover, the -491A/-427T/APOE4/APOC1A haplotype was threefold higher for patients. These results contribute to the evidence that regulation of APOE4 expression modulates risk for Alzheimer's disease.
机译:阿尔茨海默氏病是一种复杂的神经退行性疾病,其特征是进行性认知功能减退和独特的神经病理学。载脂蛋白基因E4等位基因(APOE 4)是该疾病的主要危险因素。 -491和-427的启动子多态性也可能会增加风险。我们检查了178名阿尔茨海默氏病患者和141名对照的两种多态性。在患者中,-491AA基因型过高(68%vs 54%,P = 0.01)。但是,在携带APOE4的患者中,-491AA基因型的风险增加了一倍以上[几率(OR)= 2.5; 95%置信区间(CI)= 1.2-5.4],特别是与-427TT组合使用[赔率(OR)= 3.3; 95%置信区间(CI)= 1.5-7.7]。此外,患者的-491A / -427T / APOE4 / APOC1A单倍型高三倍。这些结果有助于证明APOE4表达的调节可调节阿尔茨海默氏病的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号